Return to search results
Posaconazole
Posaconazole is an intravenous antifungal medication used to treat fungal infections. This generic drug, manufactured by Glenmark Pharmaceuticals Inc., USA, comes as a 300 mg/16.7 mL (18 mg/mL) solution in a vial. Approved under ANDA217553, it belongs to the azole antifungal class and is available by prescription since July 2024. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Posaconazole is an intravenous antifungal medication used to treat fungal infections. This generic drug, manufactured by Glenmark Pharmaceuticals Inc., USA, comes as a 300 mg/16.7 mL (18 mg/mL) solution in a vial. Approved under ANDA217553, it belongs to the azole antifungal class and is available by prescription since July 2024. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Posaconazole",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Posaconazole — ANDA 216488 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216488"
}
]
|
| identifier | ANDA216488 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Posaconazole |
